Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF

N. I. Wolf, M. A.A.P. Willemsen, U. F. Engelke, M. S. Van Der Knaap, P. J.W. Pouwels, I. Harting, J. Zschocke, E. A. Sistermans, D. Rating, R. A. Wevers

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Two unrelated girls had early onset of nystagmus and epilepsy, absent psychomotor development, and almost complete absence of myelin on cerebral MRI. The clinical features and MR images of both patients resembled the connatal form of Pelizaeus-Merzbacher disease (PMD), which is an X-linked recessive disorder caused by duplications or mutations of the proteolipid protein gene (PLP). Objective: To define a unique neurometabolic disorder with failure of myelination. Methods and Results: 1H-NMR of CSF in both girls was performed repeatedly, and both showed highly elevated concentrations of N-acetylaspartylglutamate (NAAG). The coding sequence of the gene coding for glutamate carboxypeptidase II, which converts NAAG to N-acetylaspartate (NAA) and glutamate, was entirely sequenced but revealed no mutations. Even though both patients are girls, the authors sequenced the PLP gene and found no abnormality. Conclusions: NAAG is an abundant peptide neurotransmitter whose exact role is unclear. NAAG is implicated in two cases of unresolved severe CNS disorder. Its elevated concentration in CSF may be the biochemical hallmark for a novel neurometabolic disorder. The cause of its accumulation is still unclear.

Original languageEnglish
Pages (from-to)1503-1508
Number of pages6
JournalNeurology
Volume62
Issue number9
DOIs
Publication statusPublished - 11 May 2004

Cite this

Wolf, N. I. ; Willemsen, M. A.A.P. ; Engelke, U. F. ; Van Der Knaap, M. S. ; Pouwels, P. J.W. ; Harting, I. ; Zschocke, J. ; Sistermans, E. A. ; Rating, D. ; Wevers, R. A. / Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF. In: Neurology. 2004 ; Vol. 62, No. 9. pp. 1503-1508.
@article{4881716d2205497ba4e77daf045122d8,
title = "Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF",
abstract = "Background: Two unrelated girls had early onset of nystagmus and epilepsy, absent psychomotor development, and almost complete absence of myelin on cerebral MRI. The clinical features and MR images of both patients resembled the connatal form of Pelizaeus-Merzbacher disease (PMD), which is an X-linked recessive disorder caused by duplications or mutations of the proteolipid protein gene (PLP). Objective: To define a unique neurometabolic disorder with failure of myelination. Methods and Results: 1H-NMR of CSF in both girls was performed repeatedly, and both showed highly elevated concentrations of N-acetylaspartylglutamate (NAAG). The coding sequence of the gene coding for glutamate carboxypeptidase II, which converts NAAG to N-acetylaspartate (NAA) and glutamate, was entirely sequenced but revealed no mutations. Even though both patients are girls, the authors sequenced the PLP gene and found no abnormality. Conclusions: NAAG is an abundant peptide neurotransmitter whose exact role is unclear. NAAG is implicated in two cases of unresolved severe CNS disorder. Its elevated concentration in CSF may be the biochemical hallmark for a novel neurometabolic disorder. The cause of its accumulation is still unclear.",
author = "Wolf, {N. I.} and Willemsen, {M. A.A.P.} and Engelke, {U. F.} and {Van Der Knaap}, {M. S.} and Pouwels, {P. J.W.} and I. Harting and J. Zschocke and Sistermans, {E. A.} and D. Rating and Wevers, {R. A.}",
year = "2004",
month = "5",
day = "11",
doi = "10.1212/01.WNL.0000123094.13406.20",
language = "English",
volume = "62",
pages = "1503--1508",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF. / Wolf, N. I.; Willemsen, M. A.A.P.; Engelke, U. F.; Van Der Knaap, M. S.; Pouwels, P. J.W.; Harting, I.; Zschocke, J.; Sistermans, E. A.; Rating, D.; Wevers, R. A.

In: Neurology, Vol. 62, No. 9, 11.05.2004, p. 1503-1508.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF

AU - Wolf, N. I.

AU - Willemsen, M. A.A.P.

AU - Engelke, U. F.

AU - Van Der Knaap, M. S.

AU - Pouwels, P. J.W.

AU - Harting, I.

AU - Zschocke, J.

AU - Sistermans, E. A.

AU - Rating, D.

AU - Wevers, R. A.

PY - 2004/5/11

Y1 - 2004/5/11

N2 - Background: Two unrelated girls had early onset of nystagmus and epilepsy, absent psychomotor development, and almost complete absence of myelin on cerebral MRI. The clinical features and MR images of both patients resembled the connatal form of Pelizaeus-Merzbacher disease (PMD), which is an X-linked recessive disorder caused by duplications or mutations of the proteolipid protein gene (PLP). Objective: To define a unique neurometabolic disorder with failure of myelination. Methods and Results: 1H-NMR of CSF in both girls was performed repeatedly, and both showed highly elevated concentrations of N-acetylaspartylglutamate (NAAG). The coding sequence of the gene coding for glutamate carboxypeptidase II, which converts NAAG to N-acetylaspartate (NAA) and glutamate, was entirely sequenced but revealed no mutations. Even though both patients are girls, the authors sequenced the PLP gene and found no abnormality. Conclusions: NAAG is an abundant peptide neurotransmitter whose exact role is unclear. NAAG is implicated in two cases of unresolved severe CNS disorder. Its elevated concentration in CSF may be the biochemical hallmark for a novel neurometabolic disorder. The cause of its accumulation is still unclear.

AB - Background: Two unrelated girls had early onset of nystagmus and epilepsy, absent psychomotor development, and almost complete absence of myelin on cerebral MRI. The clinical features and MR images of both patients resembled the connatal form of Pelizaeus-Merzbacher disease (PMD), which is an X-linked recessive disorder caused by duplications or mutations of the proteolipid protein gene (PLP). Objective: To define a unique neurometabolic disorder with failure of myelination. Methods and Results: 1H-NMR of CSF in both girls was performed repeatedly, and both showed highly elevated concentrations of N-acetylaspartylglutamate (NAAG). The coding sequence of the gene coding for glutamate carboxypeptidase II, which converts NAAG to N-acetylaspartate (NAA) and glutamate, was entirely sequenced but revealed no mutations. Even though both patients are girls, the authors sequenced the PLP gene and found no abnormality. Conclusions: NAAG is an abundant peptide neurotransmitter whose exact role is unclear. NAAG is implicated in two cases of unresolved severe CNS disorder. Its elevated concentration in CSF may be the biochemical hallmark for a novel neurometabolic disorder. The cause of its accumulation is still unclear.

UR - http://www.scopus.com/inward/record.url?scp=2342659631&partnerID=8YFLogxK

U2 - 10.1212/01.WNL.0000123094.13406.20

DO - 10.1212/01.WNL.0000123094.13406.20

M3 - Article

VL - 62

SP - 1503

EP - 1508

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 9

ER -